NANNanosonics Limited

NAN Stock Price, Valuation & Chart | Nanosonics Limited

$3.630+0.03 (+0.83%)

At close · 21 Aug 2026, 06:10 am

Sector: Healthcare Industry: Medical - Instruments & Supplies NAN intrinsic value Is NAN overvalued or undervalued Website

Overview Financials Dividends Ratios

NAN Historical price chart

NAN Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization1.09B

PE Ratio54.59

EPS0.07

Trading Volume755.71K

Today's High/Low3.65/3.55

Dividend Yield0.00

52 Week High/Low4.77/2.94

Shares Outstanding298.91M

NAN Financial Statement

NAN Analyst ratings

Buy

Strong buy

Buy

Hold

Sell

Strong sell

Based on 8 analysts giving stock ratings to NAN in the past 3 months.

NAN Analysis & performance metrics

NAN Company profile

Nanosonics Limited, together with its subsidiaries, operates as an infection prevention company in Australia and internationally. The company engages in the manufacturing and…

Nanosonics Limited, together with its subsidiaries, operates as an infection prevention company in Australia and internationally. The company engages in the manufacturing and distribution of the trophon ultrasound probe disinfector, and its associated consumables and accessories; and research, development, and commercialization of infection control and decontamination products and…

NAN Management team

Name

Position

Jason BurrissCFO

Chief Financial Officer

Michael C. Kavanagh BSc, M.B.A.CEO

Chief Executive Officer, President, MD & Executive Director

Rod Lopez M.B.A.COO

Chief Operating Officer & Regional President for Asia Pacific

Sunny PillaiCTO

Chief Information Officer

Ronan Wright B.E., B.Sc.

Regional President of Europe, Middle East & Africa (EMEA)

Ken Shaw B.Sc.

Regional President of United States, Canada & Latin America

Jodi Sampson M.A.I.C.D., M.B.A.

Chief People & Culture Officer

Matthew Carbines B.Com., L.L.B.

General Counsel & Company Secretary

Name

Position

Jason BurrissCFO

Chief Financial Officer

Michael C. Kavanagh BSc, M.B.A.CEO

Chief Executive Officer, President, MD & Executive Director

Rod Lopez M.B.A.COO

Chief Operating Officer & Regional President for Asia Pacific

Sunny PillaiCTO

Chief Information Officer

Ronan Wright B.E., B.Sc.

Regional President of Europe, Middle East & Africa (EMEA)

Ken Shaw B.Sc.

Regional President of United States, Canada & Latin America

Jodi Sampson M.A.I.C.D., M.B.A.

Chief People & Culture Officer

Matthew Carbines B.Com., L.L.B.

General Counsel & Company Secretary

Management Team

Jason BurrissCFO

Chief Financial Officer

Michael C. Kavanagh BSc, M.B.A.CEO

Chief Executive Officer, President, MD & Executive Director

Rod Lopez M.B.A.COO

Chief Operating Officer & Regional President for Asia Pacific

Sunny PillaiCTO

Chief Information Officer

Ronan Wright B.E., B.Sc.

Regional President of Europe, Middle East & Africa (EMEA)

Ken Shaw B.Sc.

Regional President of United States, Canada & Latin America

Jodi Sampson M.A.I.C.D., M.B.A.

Chief People & Culture Officer

Matthew Carbines B.Com., L.L.B.

General Counsel & Company Secretary

Management

Jason BurrissCFO

Chief Financial Officer

Michael C. Kavanagh BSc, M.B.A.CEO

Chief Executive Officer, President, MD & Executive Director

Rod Lopez M.B.A.COO

Chief Operating Officer & Regional President for Asia Pacific

Sunny PillaiCTO

Chief Information Officer

Ronan Wright B.E., B.Sc.

Regional President of Europe, Middle East & Africa (EMEA)

Ken Shaw B.Sc.

Regional President of United States, Canada & Latin America

Jodi Sampson M.A.I.C.D., M.B.A.

Chief People & Culture Officer

Matthew Carbines B.Com., L.L.B.

General Counsel & Company Secretary

Total 8 executives

NAN Frequently asked questions

What is Nanosonics Limited (NAN) Stock Price?

Current stock price of Nanosonics Limited (NAN) stock is $3.630. The stock price is +0.83% higher in the session. The intraday range can be seen from this page. Volume of Nanosonics Limited (NAN) stock is 755.71K.

Last updated at 21 Aug 2026, 06:10 am.

Why is the Nanosonics Limited (NAN) stock price going up or down today?

The stock price of Nanosonics Limited (NAN) can change with earnings, company news, and overall market sentiment. Nanosonics Limited operates in the Healthcare / Medical - Instruments & Supplies market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Nanosonics Limited stock expensive at its current price?

Whether Nanosonics Limited looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for NAN on this page is 54.59. EPS on this page is 0.07. Compare those figures with peers and growth expectations before deciding if the current Nanosonics Limited price is justified.

How has the stock price of Nanosonics Limited (NAN) performed historically?

Historical performance for Nanosonics Limited (NAN) is shown on the price chart on this page. Review multi-period moves alongside volume to see how NAN reacted to past earnings and market events.

Should I buy Nanosonics Limited (NAN) stock, at this price?

Buying Nanosonics Limited (NAN) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.